Atrial Fibrillation Clinical Trials in San Francisco, California

4 studies are recruiting for atrial fibrillation in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

    The main goal of this study is to find out how well BAY 3670549 works, how safe it is, how well people can tolerate it, and how the body handles the medicine. The study will compare BAY 3670549 to a placebo (a dummy treatment with no active medicine) in people with AF who need a treatment called el…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    UCSF Advanced Heart Failure Comprehensive Care Center, San Francisco, California
    Locations
    29 in total
    Run by
    Bayer

    See if you can join NCT07625215 on ClinicalTrials.gov

  2. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

    REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in parti…

    Stage
    Phase 3
    Ages
    22 to 85
    Site
    Kaiser Permanente, San Francisco, California
    Locations
    93 in total
    Run by
    Johns Hopkins University

    See if you can join NCT05836987 on ClinicalTrials.gov

  3. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    San Francisco General Hospital, San Francisco, California
    Locations
    187 in total
    Run by
    Yale University

    See if you can join NCT03907046 on ClinicalTrials.gov

  4. Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation

    VIBRANT-AF seeks to: * Identify clinically relevant predictors of effectiveness and complications of AF ablation procedures in a prospective, US-based, multi-center, real-world longitudinal study * Assess changes in modifiable lifestyle-related exposures influence the effectiveness of AF ablation *…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco

    See if you can join NCT05504356 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.